IL150565A0 - Benzimidazole derivatives and pharmaceutical compositions containing the same - Google Patents
Benzimidazole derivatives and pharmaceutical compositions containing the sameInfo
- Publication number
- IL150565A0 IL150565A0 IL15056501A IL15056501A IL150565A0 IL 150565 A0 IL150565 A0 IL 150565A0 IL 15056501 A IL15056501 A IL 15056501A IL 15056501 A IL15056501 A IL 15056501A IL 150565 A0 IL150565 A0 IL 150565A0
- Authority
- IL
- Israel
- Prior art keywords
- halo
- optionally substituted
- oxo
- trihalomethyl
- alk
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000007533 | 2000-01-17 | ||
JP2000392303 | 2000-12-25 | ||
PCT/JP2001/000271 WO2001053291A1 (fr) | 2000-01-17 | 2001-01-17 | Derives benzimidazoles |
Publications (1)
Publication Number | Publication Date |
---|---|
IL150565A0 true IL150565A0 (en) | 2003-02-12 |
Family
ID=26583615
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15056501A IL150565A0 (en) | 2000-01-17 | 2001-01-17 | Benzimidazole derivatives and pharmaceutical compositions containing the same |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP1249450B1 (fr) |
JP (1) | JP4059671B2 (fr) |
KR (2) | KR100763779B1 (fr) |
CN (2) | CN1198819C (fr) |
AT (1) | ATE375156T1 (fr) |
AU (2) | AU777813B2 (fr) |
CA (1) | CA2396908A1 (fr) |
CZ (1) | CZ301504B6 (fr) |
DE (1) | DE60130865T2 (fr) |
DK (1) | DK1249450T3 (fr) |
ES (1) | ES2295128T3 (fr) |
HK (1) | HK1050009A1 (fr) |
IL (1) | IL150565A0 (fr) |
NO (1) | NO324049B1 (fr) |
NZ (1) | NZ520028A (fr) |
PT (1) | PT1249450E (fr) |
RU (1) | RU2263674C2 (fr) |
SI (1) | SI1249450T1 (fr) |
WO (1) | WO2001053291A1 (fr) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002066457A1 (fr) * | 2001-02-22 | 2002-08-29 | Teijin Limited | Derive benzo[b]thiophene et procede de production correspondant |
US6774245B2 (en) | 2001-05-07 | 2004-08-10 | Teijin Limited | 3-Hydroxymethylbenzo[b]thiophene derivatives and process for their preparation |
KR100902799B1 (ko) * | 2001-08-24 | 2009-06-12 | 데이진 가부시키가이샤 | 키마제 저해제 및 ace 저해제를 유효성분으로 함유하는약제 |
CL2004001034A1 (es) | 2003-05-14 | 2005-03-28 | Teijin Pharma Ltd | Formas cristalinas de acido 4-(1-((,etilbenzotiofen-3-il)me til)benzimidazol-2-iltio)butanoico; procedimiento de preparacion de las formas cristalinas; composicion farmaceutica; y su uso para el tratamiento de enfermedades inflamatorias, alergicas, r |
KR20060120601A (ko) * | 2003-08-22 | 2006-11-27 | 데이진 화-마 가부시키가이샤 | 키마제 저해제를 유효 성분으로서 함유하는 약제 |
WO2006052026A1 (fr) * | 2004-11-12 | 2006-05-18 | Teijin Pharma Limited | Sel acide de derive de benzimidazole et cristal dudit sel |
CA2619744C (fr) | 2005-08-18 | 2014-09-02 | Teijin Pharma Limited | Formulation avec fonction de division en doses precises |
CA2619745A1 (fr) | 2005-08-18 | 2007-02-22 | Teijin Pharma Limited | Comprime avec des sections contenant de multiples medicaments |
EP1947097A1 (fr) | 2005-10-27 | 2008-07-23 | Teijin Pharma Limited | Derive de benzoýb¨thiophene et procede permettant de produire ce derive |
KR20080058430A (ko) | 2005-10-27 | 2008-06-25 | 데이진 화-마 가부시키가이샤 | 3-히드록시메틸벤조〔b〕티오펜 유도체 및 그 제조 방법 |
PE20070698A1 (es) | 2005-11-14 | 2007-08-17 | Teijin Pharma Ltd | Comprimido de disgregacion rapida intraoral que contiene hidrocloruro de ambroxol |
UA95788C2 (en) * | 2005-12-15 | 2011-09-12 | Ф. Хоффманн-Ля Рош Аг | Fused pyrrole derivatives |
EP2152674B1 (fr) * | 2007-05-22 | 2011-08-03 | Boehringer Ingelheim International GmbH | Inhibiteurs de benzimidazolone chymase |
MX2009012749A (es) | 2007-05-25 | 2010-03-10 | Abbott Gmbh & Co Kg | Compuestos heterociclicos como moduladores positivos del receptor de glutamato metabotropico 2 (receptor mglu2). |
TW200916098A (en) * | 2007-06-14 | 2009-04-16 | Teijin Pharma Ltd | Agent for lowering uric acid level |
WO2009133964A1 (fr) * | 2008-04-28 | 2009-11-05 | 国立大学法人九州大学 | Agent pour la prévention du stress oxydatif |
EP2364313B1 (fr) | 2008-09-09 | 2014-01-08 | Boehringer Ingelheim International GmbH | Inhibiteurs d'aza-benzimidazolone chymase |
MX2011003239A (es) | 2008-09-26 | 2011-04-28 | Merck Sharp & Dohme | Nuevos derivados de bencimidazol ciclicos utiles como agentes anti-diabeticos. |
AU2009307884B2 (en) | 2008-10-22 | 2014-07-31 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
MX2011004505A (es) | 2008-10-29 | 2011-05-31 | Merck Sharp & Dohme | Derivados novedosos de bencimidazol ciclico, utiles como agentes antidiabeticos. |
US8329914B2 (en) | 2008-10-31 | 2012-12-11 | Merck Sharp & Dohme Corp | Cyclic benzimidazole derivatives useful as anti-diabetic agents |
RU2542582C2 (ru) * | 2009-11-18 | 2015-02-20 | Астразенека Аб | Производные бензимидазола, полезные при лечении состояний, ассоциированных с активностью р2х3 или р2х2/3 |
WO2011106273A1 (fr) | 2010-02-25 | 2011-09-01 | Merck Sharp & Dohme Corp. | Nouveaux dérivés benzimidazole cycliques utiles comme agents antidiabétiques |
US8796258B2 (en) | 2011-02-25 | 2014-08-05 | Merck Sharp & Dohme Corp. | Cyclic azabenzimidazole derivatives useful as anti-diabetic agents |
AP2014008040A0 (en) * | 2012-05-04 | 2014-10-31 | Novartis Ag | Complement pathway modulators and uses thereof |
US20140045746A1 (en) | 2012-08-02 | 2014-02-13 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
EP2888007B1 (fr) | 2012-08-22 | 2019-09-18 | Merck Sharp & Dohme Corp. | Dérivés de benzimidazole tétrahydrofurane en tant qu'activateurs de la protéine kinase activée par l'amp |
ES2755087T3 (es) | 2012-08-22 | 2020-04-21 | Merck Sharp & Dohme | Derivados de benzimidazol hexahidrofuro[3,2-b]furano útiles como activadores de proteína cinasa activada por AMP |
WO2014031465A1 (fr) | 2012-08-22 | 2014-02-27 | Merck Sharp & Dohme Corp. | Nouveaux dérivés d'azabenzimidazole tétrahydropyrane |
US9868733B2 (en) | 2012-08-22 | 2018-01-16 | Merck Sharp & Dohme Corp. | Azabenzimidazole tetrahydrofuran derivatives |
BR112015003109A2 (pt) | 2012-08-22 | 2017-08-15 | Merck Sharp & Dohme | Composto, composição, uso de um composto, e, métodos para tratar ou prevenir um distúrbio, condição ou doença e para tratar diabetes mellitus tipo 2. |
EP2906040B1 (fr) | 2012-08-22 | 2021-02-17 | Merck Sharp & Dohme Corp. | Nouveaux dérivés de benzimidazole tétrahydropyrane |
EP2970119B1 (fr) | 2013-03-14 | 2021-11-03 | Merck Sharp & Dohme Corp. | Nouveaux dérivés d'indole utiles en tant qu'agents antidiabétiques |
WO2015051496A1 (fr) | 2013-10-08 | 2015-04-16 | Merck Sharp & Dohme Corp. | Composés tricycliques antidiabétiques |
US10519115B2 (en) | 2013-11-15 | 2019-12-31 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
WO2015089809A1 (fr) | 2013-12-19 | 2015-06-25 | Merck Sharp & Dohme Corp. | Composés hétéroaryles substitués antidiabétiques |
CN111004125B (zh) * | 2019-12-24 | 2022-11-22 | 东华理工大学 | 一种缩醛或缩酮化合物的制备方法 |
CN116903541B (zh) * | 2023-08-14 | 2023-12-08 | 中国环境科学研究院 | 用于酚类污染物检测的酰基咪唑类化合物、制备方法及应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2430950A1 (fr) * | 1978-07-10 | 1980-02-08 | Delalande Sa | Nouveaux derives heterocycliques de la benzimidazole, leur procede de preparation et leur application en therapeutique |
DE2928055A1 (de) * | 1978-07-12 | 1980-01-31 | Eastman Kodak Co | Verfahren zur verbesserung der widerstandsfaehigkeit von polyesterformkoerpern gegenueber einem abbau durch u.v.- licht |
JPS62212386A (ja) * | 1986-03-14 | 1987-09-18 | Suntory Ltd | 2−ピリジルメチルベンズイミダゾ−ル誘導体 |
JPH01265089A (ja) * | 1988-04-15 | 1989-10-23 | Zeria Pharmaceut Co Ltd | 新規1−(イミダゾール−4−イル)メチルベンズイミダゾール誘導体およびその製造法ならびにこれを含有する抗潰瘍剤 |
GB9225141D0 (en) * | 1992-12-01 | 1993-01-20 | Smithkline Beecham Corp | Chemical compounds |
US5527597A (en) * | 1995-03-01 | 1996-06-18 | Southern Mills, Inc. | Stretchable flame resistant fabric |
WO1999026932A1 (fr) * | 1997-11-26 | 1999-06-03 | Axys Pharmaceuticals, Inc. | Derives heterocycliques substitues par un groupe amidino et leur utilisation en tant qu'anticoagulants |
AU758789B2 (en) * | 1998-07-15 | 2003-03-27 | Teijin Limited | Thiobenzimidazole derivatives |
TR200103805T2 (tr) * | 1999-06-28 | 2002-06-21 | Janssen Pharmaceutica N.V. | Solunum sistemi sinsitiyal virüsünün replikasyonunu inhibe edici maddeler |
CZ2001153A3 (cs) * | 1999-07-14 | 2001-06-13 | Teijin Ltd | Thiobenzimidazolové deriváty |
-
2001
- 2001-01-17 ES ES01901397T patent/ES2295128T3/es not_active Expired - Lifetime
- 2001-01-17 KR KR1020027009200A patent/KR100763779B1/ko not_active IP Right Cessation
- 2001-01-17 CN CNB018066623A patent/CN1198819C/zh not_active Expired - Fee Related
- 2001-01-17 AU AU27049/01A patent/AU777813B2/en not_active Ceased
- 2001-01-17 KR KR1020077010650A patent/KR20070057276A/ko active IP Right Grant
- 2001-01-17 PT PT01901397T patent/PT1249450E/pt unknown
- 2001-01-17 AT AT01901397T patent/ATE375156T1/de not_active IP Right Cessation
- 2001-01-17 CA CA002396908A patent/CA2396908A1/fr not_active Abandoned
- 2001-01-17 WO PCT/JP2001/000271 patent/WO2001053291A1/fr active IP Right Grant
- 2001-01-17 RU RU2002122105/04A patent/RU2263674C2/ru not_active IP Right Cessation
- 2001-01-17 IL IL15056501A patent/IL150565A0/xx not_active IP Right Cessation
- 2001-01-17 NZ NZ520028A patent/NZ520028A/en unknown
- 2001-01-17 DK DK01901397T patent/DK1249450T3/da active
- 2001-01-17 SI SI200130792T patent/SI1249450T1/sl unknown
- 2001-01-17 JP JP2001553765A patent/JP4059671B2/ja not_active Expired - Fee Related
- 2001-01-17 CN CNB2005100526041A patent/CN100415723C/zh not_active Expired - Fee Related
- 2001-01-17 CZ CZ20022442A patent/CZ301504B6/cs not_active IP Right Cessation
- 2001-01-17 DE DE60130865T patent/DE60130865T2/de not_active Expired - Lifetime
- 2001-01-17 EP EP01901397A patent/EP1249450B1/fr not_active Expired - Lifetime
-
2002
- 2002-07-16 NO NO20023415A patent/NO324049B1/no not_active IP Right Cessation
-
2003
- 2003-03-31 HK HK03102300A patent/HK1050009A1/xx not_active IP Right Cessation
-
2005
- 2005-01-14 AU AU2005200172A patent/AU2005200172B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
KR20070057276A (ko) | 2007-06-04 |
JP4059671B2 (ja) | 2008-03-12 |
AU2704901A (en) | 2001-07-31 |
RU2002122105A (ru) | 2004-01-10 |
KR20020065929A (ko) | 2002-08-14 |
KR100763779B1 (ko) | 2007-10-05 |
NO20023415L (no) | 2002-07-16 |
CN100415723C (zh) | 2008-09-03 |
CN1198819C (zh) | 2005-04-27 |
HK1050009A1 (en) | 2003-06-06 |
CN1680339A (zh) | 2005-10-12 |
EP1249450B1 (fr) | 2007-10-10 |
AU2005200172B2 (en) | 2007-08-23 |
CA2396908A1 (fr) | 2001-07-26 |
NO20023415D0 (no) | 2002-07-16 |
DE60130865D1 (de) | 2007-11-22 |
CZ301504B6 (cs) | 2010-03-24 |
AU2005200172A1 (en) | 2005-02-10 |
ATE375156T1 (de) | 2007-10-15 |
DK1249450T3 (da) | 2008-02-11 |
EP1249450A1 (fr) | 2002-10-16 |
AU777813B2 (en) | 2004-11-04 |
EP1249450A4 (fr) | 2003-04-09 |
DE60130865T2 (de) | 2008-07-17 |
PT1249450E (pt) | 2008-01-02 |
NO324049B1 (no) | 2007-08-06 |
RU2263674C2 (ru) | 2005-11-10 |
SI1249450T1 (sl) | 2008-04-30 |
ES2295128T3 (es) | 2008-04-16 |
NZ520028A (en) | 2004-07-30 |
WO2001053291A1 (fr) | 2001-07-26 |
CN1418211A (zh) | 2003-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL150565A0 (en) | Benzimidazole derivatives and pharmaceutical compositions containing the same | |
ES2625944T3 (es) | Inhibidores de tirosina cinasa de Bruton | |
NO20062004L (no) | Forlenget frigjoring farmasoytiske blandinger omfattene aplindor og derivater derav | |
HK1086267A1 (en) | Pyrimidin-2-one compounds and their use as dopamine d3 receptor ligands | |
YU68102A (sh) | Derivati karboksilne kiseline kao ip antagonisti | |
DE69132713D1 (de) | Benzylidenthiazolidinderivate, ihre Herstellung und ihre Anwendung als Lipidperoxid-Inhibitoren | |
TW200504085A (en) | Derivatives of [2-(8,9-dioxo-2, 6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic acid and methods of use thereof | |
IL162614A (en) | Alpha tocopherol esters for use in treating culture-borne cell disease by aerosol administration | |
ATE502936T1 (de) | 2, 6-di-(hetero-)aryl-4-amido-pyrimidine als adenosin-rezeptor-antagonisten | |
HK1122019A1 (en) | Substituted imidazoline derivatives | |
ATE149165T1 (de) | Stickstoff enthaltende bizyklische derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
JP2000516257A5 (fr) | ||
ES2172436A1 (es) | Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos. | |
MY113529A (en) | New derivatives of imidazole n- benzyldioxole,processes for their preparation, their use as medicaments and pharmaceutical compositions containing them | |
EP0673938A3 (fr) | ||
MXPA05014127A (es) | Uso de derivados de biciclo[2.2.1]heptano para la preparacion de composiciones farmaceuticas neuroprotectoras. | |
DE69704329D1 (de) | N-benzylpiperazinderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen | |
DE69414396D1 (de) | Acylphenylglycin-derivat und dieses als aktivbestandteil enthaltendes vorbeugungs -und heilmittel gegen durch erhöhte collagenaseaktivität verursachte krankheiten | |
BR0108251A (pt) | Derivado de pirrolopiridazina ou um sal deste farmaceuticamente aceitável, composição farmacêutica, agente contendo um derivado de pirrolopiridazina ou um sal deste farmaceuticamente aceitável, e, uso de um derivado de pirrolopiridazina ou um sal deste farmaceuticamente aceitável | |
HUP0002715A2 (hu) | Benzotiofénszármazékok alkalmazása trombocitaszám csökkentésére szolgáló gyógyszerkészítmények előállítására | |
JPH083044A (ja) | 骨粗鬆症の予防または治療剤 | |
AR035219A1 (es) | Compuesto de 1, 2, 3, 4, 4a, 5, 6, 7, 8, 8 a-decahidroisoquinolina, su uso para preparar una composicion farmaceutica, dicha composicion farmaceutica y procedimiento para preparar dicho compuesto | |
RS20050426A (en) | Substituted aralkyl derivatives | |
HUP0204131A2 (hu) | Szacharinszármazékok, mint orálisan aktív elasztáz inhibitorok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
DE69904427D1 (de) | Benzothiophenderivate als antithrombotische Mitteln und Zwischenprodukte |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |